Clincosm LogoSign in Get a demo

esophagogastric junction cancer

Showing 1 - 11 of 11
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Esophageal Cancer, Esophagogastric Junction Cancer Trial in Worldwide (Autologous genetically modified ADP-A2M4CD8 cells)

Recruiting
  • Esophageal Cancer
  • Esophagogastric Junction Cancer
  • Autologous genetically modified ADP-A2M4CD8 cells
  • Duarte, California
  • +33 more
Aug 23, 2022

Esophagus Cancer, Esophagogastric Junction Cancer, Chemoradiation Trial in China (Radiotherapy, Platinum based chemo, Paclitaxel

Recruiting
  • Esophagus Cancer
  • +5 more
  • Radiotherapy
  • +5 more
  • Anyang, Henan, China
  • +4 more
Aug 17, 2022

Oncology, Melanoma, Ovarian Cancer Trial in United States (E-602, Pembrolizumab)

Recruiting
  • Oncology
  • +16 more
  • E-602
  • Pembrolizumab
  • Grand Rapids, Michigan
  • +4 more
May 27, 2022

Advanced Solid Tumors, Gastric Cancer, Esophagogastric Junction Cancer Trial in Beijing (IM92 CAR-T cells)

Recruiting
  • Advanced Solid Tumors
  • +3 more
  • IM92 CAR-T cells
  • Beijing, Beijing, China
    Chinese PLA GENERAL HOSPITAL
Mar 10, 2022

Esophageal Cancer, Esophagogastric Junction Cancer Trial in Lexington (drug, radiation, procedure)

Not yet recruiting
  • Esophageal Cancer
  • Esophagogastric Junction Cancer
  • Intravenous Tislelizumab
  • +3 more
  • Lexington, Kentucky
    University of Kentucky
Feb 21, 2022

Development ofClinical Decision Support System With Artificial

Unknown status
  • Gastric Cancer
  • +2 more
  • No intervention will be provided to the subject
  • Singapore, Singapore
    National University Hospital
Mar 7, 2021

Esophagus Cancer, Esophagogastric Junction Cancer, Radiotherapy; Complications Trial in Beijing (SIB-IMRT, S-1)

Completed
  • Esophagus Cancer
  • +3 more
  • Beijing, China
    Department of Radiation Oncology, Cancer Hospital, National Canc
Jul 18, 2020

Advanced Gastric Cancer, Esophagogastric Junction Cancer Trial in Frankfurt/Main (Paclitaxel, RAD001)

Completed
  • Advanced Gastric Cancer
  • Esophagogastric Junction Cancer
  • Frankfurt/Main, Germany
    Krankenhaus Nordwest
Jan 27, 2020

Cancer-associated Thrombosis, Esophageal Cancer, Stomach Cancer Trial in Seoul (Rivaroxaban, Dalteparin, apixaban)

Unknown status
  • Cancer-associated Thrombosis
  • +9 more
  • Seoul, Korea, Republic of
    Asan Medical Center
Jan 2, 2020

Esophagus Cancer, Esophagogastric Junction Cancer Trial in Beijing (device, radiation, drug)

Unknown status
  • Esophagus Cancer
  • Esophagogastric Junction Cancer
  • MRI and CT
  • +2 more
  • Beijing, China
    Department of Radiation Oncology, Cancer Hospital, National Canc
Dec 29, 2018

Chemotherapy for Potentially Resectable Locally Advanced

Unknown status
  • Esophagogastric Junction Cancer
    • Anyang, Henan, China
      Department of science and education
    Jul 7, 2017